Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200502794> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4200502794 endingPage "S701" @default.
- W4200502794 startingPage "S700" @default.
- W4200502794 abstract "Abstract Background Nosocomial acquisition of vancomycin-resistant Enterococcus (VRE) is one of the most challenging problems in healthcare. As Enterococcus isolates are increasingly resistant to vancomycin, clinicians now rely on alternative antimicrobial therapies including linezolid and daptomycin (DAP) to treat infections. For multidrug-resistant (MDR) VRE, combination therapy with beta-lactams and daptomycin has been shown to be effective. Methods Following initiation of empiric DAP and ceftaroline (CPT) for an MDR E. faecium bloodstream infection (VRE_001), we aimed to determine if there existed in vitro synergy between both agents that supported their clinical use. Combination synergy testing was performed using E-test strips and minimal inhibitory concentrations (MICs) were read at 24 hours. For whole genome sequence-based analysis (WGS), genomic DNA from VRE_001 was used for both short read (Illumina MiSeq) and long-read sequencing (MinION, Nanopore). The complete genome was assembled and the NCBI AMRFinderPlus program used to identify known resistance mechanisms. Results Original MICs of VRE_001 from the clinical microbiology laboratory at Northwestern Memorial revealed an MDR E. faecium (Table 1). Combination synergy testing in the experimental laboratory revealed only modest amounts of synergy between CPT and DAP (Table 2). Following WGS, VRE_001 was identified as an ST-584 E. faecium with a 3.2 Mbp genome, including a single chromosome and five plasmids. WGS analysis revealed several mechanisms of antimicrobial resistance (Table 3) genetically supporting the observed MDR-DLVRE phenotype. Conclusion Our investigational antimicrobial testing allowed for real-time in vitro analysis of synergistic MICs in a case of DLVRE bacteremia. Despite the fact that in vitro testing of CPT and DAP did not support the clinical usage of combination antimicrobial therapy, the patient cleared their blood cultures. WGS of VRE_001 revealed a plethora of antimicrobial resistance mechanisms including three mutations that explain high levels of DAP resistance. Synergy testing is not routinely available in most clinical laboratories, but rapid implementation of investigational MIC testing paired with genomic analysis may one day successfully support real-time clinical decision making. Disclosures All Authors: No reported disclosures" @default.
- W4200502794 created "2021-12-31" @default.
- W4200502794 creator A5042885634 @default.
- W4200502794 creator A5056577176 @default.
- W4200502794 creator A5062160642 @default.
- W4200502794 creator A5075226543 @default.
- W4200502794 creator A5080873388 @default.
- W4200502794 creator A5091635207 @default.
- W4200502794 date "2021-11-01" @default.
- W4200502794 modified "2023-09-29" @default.
- W4200502794 title "1221. Genomic Factors Affecting the Efficacy of Antimicrobial Therapy in Daptomycin-, Linezolid-, Vancomycin-Resistant Enterococcus faecium (DLVRE)" @default.
- W4200502794 doi "https://doi.org/10.1093/ofid/ofab466.1413" @default.
- W4200502794 hasPublicationYear "2021" @default.
- W4200502794 type Work @default.
- W4200502794 citedByCount "0" @default.
- W4200502794 crossrefType "journal-article" @default.
- W4200502794 hasAuthorship W4200502794A5042885634 @default.
- W4200502794 hasAuthorship W4200502794A5056577176 @default.
- W4200502794 hasAuthorship W4200502794A5062160642 @default.
- W4200502794 hasAuthorship W4200502794A5075226543 @default.
- W4200502794 hasAuthorship W4200502794A5080873388 @default.
- W4200502794 hasAuthorship W4200502794A5091635207 @default.
- W4200502794 hasBestOaLocation W42005027941 @default.
- W4200502794 hasConcept C126513998 @default.
- W4200502794 hasConcept C2777490607 @default.
- W4200502794 hasConcept C2777677444 @default.
- W4200502794 hasConcept C2778651397 @default.
- W4200502794 hasConcept C2778980435 @default.
- W4200502794 hasConcept C2779489039 @default.
- W4200502794 hasConcept C2779927696 @default.
- W4200502794 hasConcept C2780585763 @default.
- W4200502794 hasConcept C2781414143 @default.
- W4200502794 hasConcept C4937899 @default.
- W4200502794 hasConcept C501593827 @default.
- W4200502794 hasConcept C51679486 @default.
- W4200502794 hasConcept C523546767 @default.
- W4200502794 hasConcept C54355233 @default.
- W4200502794 hasConcept C552990157 @default.
- W4200502794 hasConcept C71924100 @default.
- W4200502794 hasConcept C86803240 @default.
- W4200502794 hasConcept C89423630 @default.
- W4200502794 hasConceptScore W4200502794C126513998 @default.
- W4200502794 hasConceptScore W4200502794C2777490607 @default.
- W4200502794 hasConceptScore W4200502794C2777677444 @default.
- W4200502794 hasConceptScore W4200502794C2778651397 @default.
- W4200502794 hasConceptScore W4200502794C2778980435 @default.
- W4200502794 hasConceptScore W4200502794C2779489039 @default.
- W4200502794 hasConceptScore W4200502794C2779927696 @default.
- W4200502794 hasConceptScore W4200502794C2780585763 @default.
- W4200502794 hasConceptScore W4200502794C2781414143 @default.
- W4200502794 hasConceptScore W4200502794C4937899 @default.
- W4200502794 hasConceptScore W4200502794C501593827 @default.
- W4200502794 hasConceptScore W4200502794C51679486 @default.
- W4200502794 hasConceptScore W4200502794C523546767 @default.
- W4200502794 hasConceptScore W4200502794C54355233 @default.
- W4200502794 hasConceptScore W4200502794C552990157 @default.
- W4200502794 hasConceptScore W4200502794C71924100 @default.
- W4200502794 hasConceptScore W4200502794C86803240 @default.
- W4200502794 hasConceptScore W4200502794C89423630 @default.
- W4200502794 hasIssue "Supplement_1" @default.
- W4200502794 hasLocation W42005027941 @default.
- W4200502794 hasLocation W42005027942 @default.
- W4200502794 hasOpenAccess W4200502794 @default.
- W4200502794 hasPrimaryLocation W42005027941 @default.
- W4200502794 hasRelatedWork W1983183130 @default.
- W4200502794 hasRelatedWork W2094025098 @default.
- W4200502794 hasRelatedWork W2120575175 @default.
- W4200502794 hasRelatedWork W2129468136 @default.
- W4200502794 hasRelatedWork W2136373969 @default.
- W4200502794 hasRelatedWork W2156781074 @default.
- W4200502794 hasRelatedWork W2179124794 @default.
- W4200502794 hasRelatedWork W2414441049 @default.
- W4200502794 hasRelatedWork W3215409706 @default.
- W4200502794 hasRelatedWork W4200502794 @default.
- W4200502794 hasVolume "8" @default.
- W4200502794 isParatext "false" @default.
- W4200502794 isRetracted "false" @default.
- W4200502794 workType "article" @default.